16:04:08 EDT Sun 14 Jun 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 18 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-06-14 15:26U:ELEKNews ReleaseElektros Inc. Advances Its Lithium and EV Innovation Strategy as Global Electrification Momentum Accelerates
2026-06-14 14:55U:ELEKNews ReleaseElektros Inc. Strengthens Its Position in Lithium and EV Innovation as the Global Electrification Era Gains Momentum
2026-06-14 14:45U:CRNXNews ReleaseCrinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY(TM) (paltusotine) Provides Durable, Consistent Acromegaly Control
2026-06-14 14:36U:ELEKNews ReleaseElektros Inc. Highlights Long-Term Lithium and EV Innovation Strategy as Global Investors Focus on the Future of Electrification
2026-06-14 14:15U:ELEKNews ReleaseElektros Inc. Embraces the Bright Future of Lithium and EV Innovation as Its Global Electrification Mission Continues to Advance
2026-06-14 11:45U:AVAVNews ReleaseAV Introduces TOM 50 RE, a Backpackable UGV for Rapid Reconnaissance and Explosive Ordnance Disposal
2026-06-14 10:21U:CLDXNews ReleaseCelldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting
2026-06-14 10:00U:UPBNews ReleaseUpstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026
2026-06-14 10:00U:MLYSNews ReleaseMineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
2026-06-14 05:15U:CLDXNews ReleaseCelldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
2026-06-14 03:15U:LLYNews ReleaseLilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
2026-06-14 03:15U:LEGNNews ReleaseLegend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
2026-06-13 22:16U:ELEKNews ReleaseElektros Inc. Ignites New Momentum Across Lithium, EV Innovation, and Critical Minerals as the Global Electrification Era Accelerates
2026-06-13 21:30U:ELEKNews ReleaseElektros Inc. Powers Ahead as Global Demand for Lithium, EV Innovation, and Critical Minerals Creates New Opportunities for Electrification
2026-06-13 21:15U:ELEKNews ReleaseElektros Inc. Accelerates Its Vision for Lithium, EV Innovation, and the Future of Electrification
2026-06-13 21:00U:ELEKNews ReleasePowering the Future of Electrification
2026-06-13 20:00U:ACDVFNews ReleaseAir Canada and the IAMAW Reach Tentative Agreement on New Contract
2026-06-13 18:15U:CYCLNews ReleaseCycclone, Inc. Announces Agreement in Principle for the Acquisition of AI Robotics Company